These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 34411603)

  • 81. Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer's Disease.
    Giau VV; Wu SY; Jamerlan A; An SSA; Kim SY; Hulme J
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30441866
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Annexin A1 restores Aβ
    Park JC; Baik SH; Han SH; Cho HJ; Choi H; Kim HJ; Choi H; Lee W; Kim DK; Mook-Jung I
    Aging Cell; 2017 Feb; 16(1):149-161. PubMed ID: 27633771
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer's Disease.
    Zhu F; Li C; Chu F; Tian X; Zhu J
    Front Aging Neurosci; 2020; 12():544235. PubMed ID: 33132894
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Vascular Risk Factors and Alzheimer's Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links.
    He JT; Zhao X; Xu L; Mao CY
    J Alzheimers Dis; 2020; 73(1):39-58. PubMed ID: 31815697
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Gut microbiota mediated allostasis prevents stress-induced neuroinflammatory risk factors of Alzheimer's disease.
    Westfall S; Iqbal U; Sebastian M; Pasinetti GM
    Prog Mol Biol Transl Sci; 2019; 168():147-181. PubMed ID: 31699313
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Gut-Brain Axis and its Neuro-Psychiatric Effects: A Narrative Review.
    Shaik L; Kashyap R; Thotamgari SR; Singh R; Khanna S
    Cureus; 2020 Oct; 12(10):e11131. PubMed ID: 33240722
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Region-specific blood-brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer's disease.
    Sekhar GN; Fleckney AL; Boyanova ST; Rupawala H; Lo R; Wang H; Farag DB; Rahman KM; Broadstock M; Reeves S; Thomas SA
    Fluids Barriers CNS; 2019 Dec; 16(1):38. PubMed ID: 31842924
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology.
    Rutsch A; Kantsjö JB; Ronchi F
    Front Immunol; 2020; 11():604179. PubMed ID: 33362788
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer's Disease.
    Wu S; Liu X; Jiang R; Yan X; Ling Z
    Front Aging Neurosci; 2021; 13():650047. PubMed ID: 34122039
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Bidirectional interactions between curcumin and gut microbiota in transgenic mice with Alzheimer's disease.
    Sun ZZ; Li XY; Wang S; Shen L; Ji HF
    Appl Microbiol Biotechnol; 2020 Apr; 104(8):3507-3515. PubMed ID: 32095862
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Impact of dietary induced precocious gut maturation on cecal microbiota and its relation to the blood-brain barrier during the postnatal period in rats.
    Marungruang N; Arévalo Sureda E; Lefrançoise A; Weström B; Nyman M; Prykhodko O; Fåk Hållenius F
    Neurogastroenterol Motil; 2018 Jun; 30(6):e13285. PubMed ID: 29327435
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?
    Pellegrini C; Antonioli L; Calderone V; Colucci R; Fornai M; Blandizzi C
    Prog Neurobiol; 2020 Aug; 191():101806. PubMed ID: 32473843
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Improving Alzheimer's disease by altering gut microbiota in tree shrews with ginsenoside Rg1.
    Wang L; Lu J; Zeng Y; Guo Y; Wu C; Zhao H; Zheng H; Jiao J
    FEMS Microbiol Lett; 2020 Feb; 367(4):. PubMed ID: 31950993
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Gut reactions: How the blood-brain barrier connects the microbiome and the brain.
    Logsdon AF; Erickson MA; Rhea EM; Salameh TS; Banks WA
    Exp Biol Med (Maywood); 2018 Jan; 243(2):159-165. PubMed ID: 29169241
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The Gut-Brain Axis in Alzheimer's Disease and Omega-3. A Critical Overview of Clinical Trials.
    La Rosa F; Clerici M; Ratto D; Occhinegro A; Licito A; Romeo M; Iorio CD; Rossi P
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30205543
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Toward Elucidating the Human Gut Microbiota-Brain Axis: Molecules, Biochemistry, and Implications for Health and Diseases.
    Lai Y; Dhingra R; Zhang Z; Ball LM; Zylka MJ; Lu K
    Biochemistry; 2022 Dec; 61(24):2806-2821. PubMed ID: 34910469
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Disturbed microbial ecology in Alzheimer's disease: evidence from the gut microbiota and fecal metabolome.
    Xi J; Ding D; Zhu H; Wang R; Su F; Wu W; Xiao Z; Liang X; Zhao Q; Hong Z; Fu H; Xiao Q
    BMC Microbiol; 2021 Aug; 21(1):226. PubMed ID: 34384375
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The microbiome and disease: reviewing the links between the oral microbiome, aging, and Alzheimer's disease.
    Shoemark DK; Allen SJ
    J Alzheimers Dis; 2015; 43(3):725-38. PubMed ID: 25125469
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Dietary Pattern, Gut Microbiota, and Alzheimer's Disease.
    Zhang M; Zhao D; Zhou G; Li C
    J Agric Food Chem; 2020 Nov; 68(46):12800-12809. PubMed ID: 32090565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.